ALACHUA, Fla.--(BUSINESS WIRE)--AxoGen, Inc. (OTCBB: AXGN) a leading regenerative medicine company dedicated to advancing the science and commercialization of peripheral nerve repair solutions, today announced that it will release its financial results for the period ended September 30, 2012, on November 7, 2012 after the close of U.S. financial markets. A conference call hosted by Karen Zaderej, Chief Executive Officer, and Greg Freitag, Chief Financial Officer, will follow at 11:00 a.m. ET, on November 8, 2012.
